Adenocarcinoma of the Minor Duodenal Papilla Mimicking a Pancreatic Head Tumor: A Rare Case Report and Review of the Literature
This case report describes a rare instance of adenocarcinoma arising from the minor duodenal papilla that mimicked a pancreatic head tumor and progressed without biliary obstruction, highlighting the diagnostic challenges posed by its anatomical proximity to the pancreas and the necessity of integrating multimodal findings for accurate identification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the human body, just behind the stomach, lies a complex junction where the digestive tract meets the pancreas and the liver. This area is a busy crossroads for fluids that help us break down food. Two small, nipple-like openings, known as papillae, serve as the exit doors for these fluids. The larger, more famous opening, called the major papilla, drains the common bile duct, which carries bile from the liver, and the main pancreatic duct. The second, much smaller opening, known as the minor papilla, handles a separate channel called the accessory pancreatic duct. Because these structures are tucked deep inside the abdomen and sit right next to the head of the pancreas, doctors often group tumors found in this neighborhood together. When a mass appears here, it is usually assumed to be a cancer of the pancreas or the major bile duct, especially if it blocks the flow of bile and causes the skin to turn yellow. However, the anatomy of this region is intricate, and the smaller, less obvious opening has its own unique relationship with the surrounding tissues.
A team of researchers from the University of Balamand in Lebanon recently shared the story of a patient who challenged these standard assumptions. They described a 72-year-old woman who arrived at their hospital suffering from a blockage in her digestive system. For four months, she had experienced difficulty swallowing, a feeling of fullness after eating very little, pain in her upper stomach, and frequent vomiting. She had also lost a significant amount of weight, dropping from 63 kilograms to 52 kilograms. Initial scans showed a mass in the area of the pancreatic head, and a biopsy suggested it was a type of cancer called adenocarcinoma. The doctors faced a difficult decision: the tumor was causing a severe blockage in the intestine, preventing food from passing, but the patient's blood tests showed no signs of the yellowing skin or liver stress that typically accompanies pancreatic cancers. Her liver enzymes and bilirubin levels were completely normal, and imaging showed that her main bile duct was not swollen. This was a puzzling contradiction, as a tumor of that size in that location usually clogs the bile duct as well.
The medical team decided to proceed with a major surgery known as a pancreaticoduodenectomy, a complex procedure that removes the head of the pancreas, the duodenum, and part of the bile duct to clear the blockage and remove the tumor. During the operation, they found the mass was indeed encasing a specific artery but had not spread to the liver or the lining of the abdomen. Once the specimen was removed and examined under a microscope, the true nature of the disease became clear. The cancer did not start in the pancreas or the major bile duct. Instead, it originated from the tiny, secondary opening—the minor papilla. The tumor had grown from this small spot, pushing through the wall of the intestine and spreading superficially into the nearby pancreas, which made it look like a pancreatic tumor on the scans. Crucially, the major papilla and the main bile duct remained untouched by the cancer. This anatomical separation explained why the patient had never developed jaundice; the tumor blocked the intestine but left the main drainage path for bile completely open.
The examination of the removed tissue provided the final answers. The cancer cells were centered on the minor papilla and had spread into the surrounding muscle and tissue, but the surgical team managed to remove the entire tumor with clear edges, leaving no cancer behind. None of the twelve lymph nodes checked contained cancer cells. The patient's blood test had shown an extremely high level of a marker called CA 19-9, a substance often associated with pancreatic cancer, yet her liver function was normal. This case demonstrated that a tumor can produce such high levels of this marker without blocking the bile duct, proving that the marker alone cannot tell doctors exactly where a tumor began. The researchers concluded that this type of cancer is likely much more common than medical records suggest, because when these tumors grow large, they invade neighboring tissues and hide their true origin. Without a careful look at the entire removed specimen, doctors might simply classify them as standard pancreatic cancers. This specific case, the first of its kind reported from the Middle East, highlights the importance of looking closely at the anatomy of the entire area to understand where a disease truly started, especially when the symptoms do not match the usual patterns.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.